What antidiarrheal medications, aside from loperamide, can be used to treat acute gastroenteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antidiarrheal Medications Beyond Loperamide

Primary Recommendation

Bismuth subsalicylate is the most appropriate alternative antidiarrheal medication to loperamide for acute gastroenteritis in adults, though it provides slower and less effective symptom relief. 1 However, oral rehydration solution (ORS) remains the cornerstone of treatment and must be prioritized before considering any antidiarrheal agent. 2, 3

Available Antidiarrheal Alternatives

Bismuth Subsalicylate (Pepto-Bismol)

  • Demonstrated efficacy in acute diarrhea but significantly inferior to loperamide in head-to-head comparison, with longer time to last unformed stool and less effective overall subjective relief at 24 hours. 1
  • Well-tolerated with minor adverse effects that rarely require discontinuation. 1
  • Appropriate for adults with acute watery diarrhea after adequate hydration is established. 1

Racecadotril

  • Can be considered as adjunctive therapy to oral rehydration in acute watery diarrhea, but provides only modest clinical benefit compared to ORS alone. 4
  • Not available in North America (United States and Canada), severely limiting its practical application. 4
  • Demonstrated efficacy in reducing stool volume in adults, but should only be used after adequate hydration is achieved. 4
  • Offers less rebound constipation compared to loperamide but lacks evaluation specifically in travelers' diarrhea and has weaker guideline support. 3

Diphenoxylate

  • Mentioned as a synthetic antidiarrheal option alongside loperamide. 5
  • May increase toxicity associated with bacterial diarrhea, similar to other antimotility agents. 5
  • Commonly used in inflammatory bowel disease settings but not specifically recommended for acute gastroenteritis. 6

Critical Contraindications for ALL Antimotility Agents

Absolute Contraindications

  • Bloody diarrhea or dysentery (blood in stools with high fever) - risk of bacterial proliferation and toxic megacolon. 3
  • Fever >38.5°C - suggests invasive pathogen. 3
  • Severe abdominal pain or distention - risk of toxic megacolon. 3
  • Suspected or confirmed C. difficile infection - risk of pseudomembranous colitis complications. 3
  • Children under 18 years of age - strongly contraindicated due to risks of respiratory depression, cardiac adverse reactions, and death. 2, 3, 7

High-Risk Populations Requiring Extreme Caution

  • Immunocompromised patients - higher risk of toxic megacolon with invasive pathogens. 3
  • Neutropenic patients - extra vigilance required as pseudomembrane formation may not occur with C. difficile. 3

Agents That Should NOT Be Used

Explicitly Not Recommended

  • Adsorbents (kaolin-pectin) - do not reduce diarrhea volume or duration; stool water losses unchanged despite improved consistency. 2
  • Antisecretory drugs - no demonstrated effectiveness in reducing diarrhea volume or duration. 2, 7
  • Toxin binders (cholestyramine) - no demonstrated effectiveness; can bind nutrients and other drugs. 2
  • Atropine-containing products - cause drowsiness and nausea. 2

Why These Agents Fail

  • Shift therapeutic focus away from appropriate fluid, electrolyte, and nutritional therapy, which are the true priorities. 2, 7
  • Can interfere with oral rehydration therapy and unnecessarily add to economic cost. 2
  • Side effects are well-documented, including opiate-induced ileus, electrolyte losses, and nutrient binding. 2
  • At least 18 cases of severe abdominal distention associated with loperamide use in children, including six deaths, highlighting the dangers of antimotility agents in inappropriate populations. 2

Treatment Algorithm

Step 1: Assess for Contraindications

  • Check for fever, bloody stools, severe abdominal pain, or suspected invasive pathogens. 3
  • Verify patient age (must be ≥18 years for any antimotility agent). 2, 3
  • Assess immune status and comorbidities. 3

Step 2: Prioritize Rehydration

  • Initiate ORS immediately - this is the first-line treatment regardless of whether antidiarrheal agents will be used. 2, 3, 7
  • For mild-moderate dehydration: 50-100 mL/kg ORS over 2-4 hours. 7
  • Replace ongoing losses: 10 mL/kg for each watery stool. 7

Step 3: Consider Antidiarrheal Agent (If Appropriate)

  • If loperamide is unavailable or contraindicated: Use bismuth subsalicylate at recommended nonprescription doses. 1
  • If in a region where racecadotril is available (not North America): Consider as adjunct to ORS after adequate hydration. 4
  • Continue monitoring for development of warning signs requiring immediate discontinuation. 3

Common Pitfalls to Avoid

  • Never delay rehydration while considering antidiarrheal options - ORS must be started immediately. 3, 7
  • Never use antimotility agents before ensuring adequate hydration - this is a critical safety principle. 3
  • Never rely on antidiarrheal agents as primary therapy - they are adjuncts only, with rehydration being the definitive treatment. 2, 7
  • Never use any antimotility agent in children - the evidence strongly opposes this practice due to serious adverse events including death. 2, 3
  • Discontinue immediately if abdominal distention occurs - this suggests possible toxic megacolon. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Appropriate Use of Anti-Motility Agents in Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Use of Racecadotril in Acute Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Drug therapy reviews: pharmacotherapy of diarrhea.

American journal of hospital pharmacy, 1979

Research

The role of loperamide in gastrointestinal disorders.

Reviews in gastroenterological disorders, 2008

Guideline

Management of Gastroenteritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.